DIPIPERAMIDE-D
Compound with spectra: 1 NMR
| SpectraBase Compound ID | kMgZn7OUiM |
|---|---|
| InChI | InChI=1S/C36H40N2O6/c39-34(37-17-3-1-4-18-37)16-13-29-27(11-7-25-9-14-30-32(21-25)43-23-41-30)28(35(29)36(40)38-19-5-2-6-20-38)12-8-26-10-15-31-33(22-26)44-24-42-31/h7-16,21-22,27-29,35H,1-6,17-20,23-24H2/b11-7+,12-8+,16-13+/t27-,28+,29+,35-/m0/s1 |
| InChIKey | ZWDCRRZEPLDPMM-DTLMASBASA-N |
| Mol Weight | 596.7 g/mol |
| Molecular Formula | C36H40N2O6 |
| Exact Mass | 596.288637 g/mol |
| Enantiomer InChIKey | ZWDCRRZEPLDPMM-GXXVPTIASA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
5-[(2E)-3-(1,3-benzodioxol-5-yl)-2-propenoyl]-6-hydroxy-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione
(2E)-3-(1,3-benzodioxol-5-yl)-N-[6-(methylsulfonyl)-1,3-benzothiazol-2-yl]-2-propenamide
3-[1-Oxo-3-(3,4-methylenedioxyphenyl)-2-propenyl]-2H-1-benzopyran-2-one Oxime
N-[(E)-2-(1,3-benzodioxol-5-yl)-1-(1-piperidinylcarbonyl)ethenyl]-2-methoxybenzamide
N-[2-(3,4-Dimethoxyphenyl)ethyl]-cis-norborn-5-en-endo-2,3-dicarboxyimide
(1E,4E)-1-(Benzo[d][1,3]dioxol-5-yl)-5-(2-butoxy-6-methylquinolin-3-yl)penta-1,4-dien-3-one
N-((Z)-2-(1,3-benzodioxol-5-yl)-1-{[(2-furylmethyl)amino]carbonyl}ethenyl)-2-methoxybenzamide
N-{(E)-2-(1,3-benzodioxol-5-yl)-1-[(4-methoxyanilino)carbonyl]ethenyl}-2-methoxybenzamide
2,4-thiazolidinedione, 5-(1,3-benzodioxol-5-ylmethylene)-3-[(2-chlorophenyl)methyl]-, (5Z)-
2,4,6(1H,3H,5H)-pyrimidinetrione, 5-(1,3-benzodioxol-5-ylmethylene)-1-[2-(4-fluorophenyl)ethyl]-, (5E)-
| Title | Journal or Book | Year |
|---|---|---|
| CYP3A4 Inhibitory Activity of New Bisalkaloids, Dipiperamides D and E, and Cognates from White Pepper | Bioorganic & Medicinal Chemistry | 2002 |
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.